Liver Fibrosis Evaluation with MRI- A Primer for Engineers, Physicists, and Technologists Artifacts in breast imaging when using SPAIR fat suppression in the presence of large B0 variations Proton MRI-based oximetry Recent advancements in multiparametric MRI methods for the early diagnosis of prostate cancer Current State and Future Directions of AI Enhanced Radiology Practice for the Development of Screening and Diagnostic Tools Workflow for spatial alignment of MR data and histopathological images of tumors for region-of-interest-based correlation analysis Absolute quantification of hepatic 31P metabolites at 3 T using a phantom replacement technique How to set it up A Primer on Blockchain in Radiology Data Ownership and Beyond Radiomics analysis in the era of quantitative imaging The benefits of ZTE to standard MRI practice Clinical Impact of Single Breath Hold Contrast Enhanced 4D-MRA with High Temporal and Spatial Resolution without k-space Data Sharing Techniques Diffusion imaging: multi-shell DTI on a whole-body 3T scanner versus a head-only MAGNUS 3T for traumatic brain injury evaluation RA synovitis segmentation based on unsupervised learning and TIC signal data on DCE-MRI Technologist Assessment of a Realtime Motion Monitoring System for fMRI Exams Evaluation of T1 relaxation time measurement using magnetic resonance spectroscopy unobstructed by the presence of fat: A liver phantom study

2004, 8: 55- Kapoor RR, Burke SA, Sparrow SE, Hughes IA, Dunger DB, Ong KK, Acerini CL: Monitoring of concordance in growth hormone therapy
doi: 10.3389/fphar.2023.1171399 Received 22 February 2023 Accepted 24 April 2023 Published 04 May 2023 Volume 14 - 2023 Edited by Dong-Hua Yang, New York College of Traditional Chinese Medicine, United States Reviewed by Benli Su, Second Hospital of Dalian Medical University, China Faisal Raza, Shanghai Jiao Tong University, China Updates Copyright 2023 Zhang, Zhang, Chen, Deng, Wu, Zhu, Chen, Duan, Zhao and Hou
That matters for protocols where TB-500 needs to run higher (such as injury-focused work)
doi: 10.1002/hsr2.1640 52 ChandrasekaranPWeiskirchen SRW
Ractigen announces positive clinical data for RAG-17 in ALS-SOD1 treatment from investigator-initiated trial